Benefit/program verification and prior authorization

Verify the member's specific Capital Blue Cross benefit program and whether prior authorization is required; this policy applies only to certain Capital Blue Cross programs and product variations (see FEP PPO referral instructions).

• Confirm member eligibility and benefit limitations on the date of service.
• If FEP PPO, follow the FEP Medical Policy Manual link referenced in the policy.
• Obtain prior authorization when required by the member's plan before scheduling services.

Prior authorization / associated codes

Prior authorization may be required for procedures and the listed HCPCS/Q-codes shown in the coding section; presence of codes in the policy's coding lists indicates association with medically necessary uses but does not by itself guarantee coverage.

• Check plan prior authorization rules for CPT codes listed in the policy's associated procedures table (e.g., 15271–15278, 15011–15018, G0681–G0683).
• Use the policy coding section to identify codes that may require authorization, then confirm with the payer.

Prior authorization for listed product codes

Certain HCPCS/Q/A codes are cross-referenced as covered or investigational in the policy; prior authorization may be required to determine coverage status and to distinguish investigational from covered products.

• Verify prior authorization requirements for cross-referenced codes such as Q4128, Q4431–Q4433 and A2001/A2005/A2006 when applicable.
• Provide documentation at authorization to show whether the requested product maps to a covered code or an investigational code per the policy.

Use current effective procedure codes

Bill using procedure and HCPCS/Q-codes that are effective on the date of service; coding lists in the policy were updated repeatedly and providers must use current effective codes per the policy history.

• Ensure the code billed matches the code effective on the date of service as listed in the policy history (multiple adds/deletes and effective dates noted).
• Outdated or deleted codes may result in claim denial—confirm current code set prior to claim submission.

Venous ulcer step

For venous insufficiency lower-extremity ulcers, tissue-engineered skin substitutes (Apligraf® or Oasis™ Wound Matrix) are considered medically necessary only after the ulcer has not adequately responded following a 1-month period of conventional ulcer therapy.

• Document failure of at least 1 month of conventional ulcer therapy before submission for authorization or billing.

Clinical indication documentation

Document the specific clinical scenario and findings that match a listed medically necessary indication (for example, inadequate implant coverage by pectoralis major, compromised thin postmastectomy skin flaps, failure of 1 month of conventional therapy for venous ulcers, HDE-specified uses for OrCel®/Epicel®).

• Include clinical notes describing the diagnosis, prior conservative treatments and duration, and operative findings when applicable.
• For HDE products, document conformity with FDA HDE specifications (e.g., Epicel® for ≥30% TBSA burns).

Documentation and coding note

Document medical necessity and member eligibility; the identification of a code in the coding section does not denote coverage—final claim processing depends on the member's benefit contract and plan terms.

• Provide clinical justification tied to policy criteria when submitting claims or authorization requests.
• Attach relevant medical records and benefit verification to support coverage determinations.

Investigational uses may be denied

Use of products or HCPCS A- and Q- codes listed under the Investigational section for indications not identified as medically necessary may be denied as investigational.

• If billing codes listed in the 'Investigational' table (e.g., A2001 series, specific Q-codes listed) for non-covered indications, expect claim denial.
• When in doubt, request prior authorization and provide evidence that the indication meets a medically necessary criterion.

Coverage contingent on medical necessity and member benefits

Coverage and payment are contingent on the member's benefit program, eligibility on the date of service, and a determination that the services are medically necessary and appropriate per the member's contract.

• Confirm member eligibility and plan-specific benefit limitations before providing services.
• Understand that policy inclusion of a product does not override the member's benefit terms.

Investigational HCPCS A- and Q- codes may trigger denial

HCPCS A- and Q-codes designated investigational in the policy cross-references (listed under the Investigational section) may trigger denials if billed for investigational uses.

• Review the policy's Investigational code list before billing to avoid submitting claims for codes that are excluded for investigational indications.
• Use authorization to clarify whether a specific code maps to a covered or investigational product for the clinical indication.

Deleted and added codes in administrative updates may trigger claim denials

Policy history shows numerous administrative additions and deletions of codes; using deleted or outdated codes from prior versions may result in claim denials—confirm current codes and effective dates prior to submission.

• Refer to the policy history for code effective dates and recent administrative updates when preparing claims.
• Replace deleted codes with the current equivalent codes effective on the date of service.